Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Dig Dis Sci. 2021 May 23;67(6):2677–2687. doi: 10.1007/s10620-021-07048-5

Fig. 2.

Fig. 2

a Percentage of HCC in non-cirrhotic and cirrhotic liver to all HCC cases, b Metavir fibrosis stage distribution of non-tumor liver in patients with HCC by etiologies of liver disease; NAFLD non-alcoholic fatty liver disease, HBV hepatitis B, HH hereditary hemochromatosis, HCV hepatitis C, A1AT alpha 1 antitrypsin deficiency